The results demonstrated that RP11-79H23.3 inhibited tumor angiogenesis, whereas si-RP11-79H23.3 led to a higher CD31 and S100A4 expression and more microvessels compared with the control group (Figure 4G). The gene discussed is S100A4; the disease is neoplasm.